ABSTRACT: This study aimed to elucidate how rats recover from immobilization-induced knee joint contracture. Rats' right knees were immobilized by an external fixator at a flexion of 140˚for 3 weeks. After removal of the fixator, the joints were allowed to move freely (remobilization) for 0, 1, 3, 7, or 14 days (n ¼ 5 each). To distinguish myogenic and arthrogenic contractures, the passive extension range of motion was measured before and after myotomy of the knee flexors. Knee joints were histologically analyzed and the expression of genes encoding inflammatory or fibrosis-related mediators, interleukin-1b (1L-1b), fibrosis-related transforming growth factor-b1 (TGF-b1), and collagen type I (COL1A1) and III (COL3A1), were examined in the knee joint posterior capsules using realtime PCR. Both myogenic and arthrogenic contractures were established within 3 weeks of immobilization. During remobilization, the myogenic contracture decreased over time. In contrast, the arthrogenic contracture developed further during the remobilization period. On day 1 of remobilization, inflammatory changes characterized by edema, inflammatory cell infiltration, and upregulation of IL-1b gene started in the knee joint posterior capsule. In addition, collagen deposition accompanied by fibroblast proliferation, with upregulation of TGF-b1, COL1A1, and COL3A1 genes, appeared in the joint capsule between days 7 and 14. These results suggest the progression of arthrogenic contracture following remobilization, which is characterized by fibrosis development, is possibly triggered by inflammation in the joint capsule. It is therefore necessary to focus on developing new treatment strategies for immobilization-induced joint contracture. ß
Joint contracture is characterized by reduced joint range of motion (ROM), 1 which limits daily living activities 2, 3 and is thus an important issue in medical care. Although joint contracture may arise from various pathological conditions, such as arthritis 4 and central nervous system diseases, 5, 6 the most common cause is joint immobilization. [7] [8] [9] The pathophysiology of joint contracture has therefore been investigated in detail using immobilized animal models. These studies show that joint contracture develops within 1 week and progresses in a time-dependent manner. [10] [11] [12] [13] [14] Joint contracture can be caused in two ways, by changes in two different structural components. Firstly, myogenic contracture is induced by changes in muscular factors, including muscles, tendons, and fascia. [10] [11] [12] Secondly, arthrogenic contracture is induced by changes in articular factors, including bones, cartilage, joint capsules, and ligaments. [10] [11] [12] In short-term immobilization (within 2-4 weeks), the joint contracture is largely myogenic, [10] [11] [12] and is resolved by remobilization. 11 When joint immobilization is prolonged (more than 2-4 weeks), arthrogenic contracture becomes the primary determinant of the severity of contracture, [10] [11] [12] mainly because of changes in the joint capsule. 15 Importantly, arthrogenic contracture does not improve spontaneously following remobilization. 11, 16, 17 The development of treatments for arthrogenic contracture is thus a necessary step to prevent the irreversible progression of joint contracture. However, joint contractures respond poorly to conventional treatments. 18 For example, passive joint movements, including stretching, are commonly applied clinical treatments against joint contracture. However, passive stretching has not been found to facilitate recovery from immobilization-induced joint contracture. 7 Furthermore, a meta-analysis concluded that stretching is not effective for treating or preventing joint contractures. 19 Understanding the recovery processes of immobilization-induced joint contracture is an essential step in developing more beneficial interventions. Compared with information on how joint contracture develops, however, we know little about its recovery processes. One study by Trudel et al. 11 separately analyzed the recovery of myogenic and arthrogenic contractures following remobilization, and found that arthrogenic contracture progressed as a result of joint remobilization, following short-term immobilization (less than 4 weeks). There are some studies reporting histological changes in joint capsules during remobilization, 16, [20] [21] [22] but the changes responsible for the remobilizationinduced aggravation of arthrogenic contracture have not yet been identified. Michelson and Hunneyball 22 observed the development of inflammation in the immobilized joint capsules of rabbits, and found that subsequent remobilization further aggravated the synovitis. In general, joint inflammation can lead to arthrofibrosis, which is characterized by collagen deposition in joint components and results in loss of ROM. [23] [24] [25] Based on these reports, we speculate that inflammation and subsequent arthrofibrosis observed early during remobilization may be a primary mechanism responsible for the progression of arthrogenic contracture.
To test this hypothesis, we investigated timedependent changes in the histopathology and gene expression of inflammatory mediator and fibrosisrelated genes, as well as joint ROMs in the knee joints after various periods of remobilization, up to 14 days.
MATERIALS AND METHODS

Experimental Animals
Twenty-five 8-week-old male Wistar rats (190-230 g; Japan SLC, Shizuoka, Japan) were used in this study. Five rats were sacrificed at each of five time points during remobilization, following 3 weeks of immobilization: day 0 (no remobilization), 1, 3, 7, and 14. Untreated contralateral (left) knees in the day 0 group were used as controls. Rats were housed in standard cages in a temperature-controlled room (20-25˚C) with 12 h light/dark cycles. Standard rodent chow and water were provided ad libitum. This experimental design was approved by the committee on animal experimentation of Hiroshima International University.
Joint Immobilization
The right knee joints of all rats were immobilized, according to the method described by Nagai et al. 10 In brief, after anesthesia by intraperitoneal injection of sodium pentobarbital (32.4 mg/kg of body weight), Kirschner wires (01-132-50; MIZUHO, Tokyo, Japan) were screwed into the femur and the tibia. The Kirschner wires were then fixed with wire and resin (PROVINICE FAST; Matsukaze, Kyoto, Japan) to immobilize the knee joint at approximately 140˚flexion. Rats could move freely using all four limbs, but with the right knee fixed at a 140˚flexed angle. After 3 weeks of this immobilization, the fixation device was removed and the knee joint was allowed to move freely for a variable number of days, as described above. Data from the day 0 group were taken immediately after removing the fixation device and were analyzed to assess the results of 3 weeks of immobilization without remobilization.
Measurement of ROM
ROM measurements were performed using the same method as in our previous study. 26 In brief, rats were deeply anesthetized by an intraperitoneal injection of sodium pentobarbital (32.4 mg/kg of body weight; if necessary, sedation was increased by inhalation of diethyl ether), and both hindlimbs were skinned. The femur was manually fixed at approximately 90˚hip flexion in the neutral spine position, and 14.6 N Á mm of knee extension moment was applied to the distal portion of the lower leg using pulley and weight (Fig. 1A) . This extension moment extended the knee joint close to its physiological limit, 27 but was much less than the torque, which leads to tearing of the soft tissue. 12 Markers were then placed on the trochanter major, the knee lateral joint space, and the lateral malleolus. The angle between the femur (trochanter major to knee lateral joint space) and fibula (knee lateral joint space to lateral malleolus) was measured as the knee extension ROM, using a 3D motion analysis system (Kinema Tracer; KISSEI COMTEC, Nagano, Japan). After the rats had been sacrificed by exsanguination under anesthesia, the knee flexor muscles were completely transected to exclude the myogenic components. Apart from other knee flexor muscles, the semitendinosus muscle was removed together with the ischial tuberosity, which is where 
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the semitendinosus muscle originates. The extension ROM was then measured again as an index of arthrogenic contracture, using the same method as was used to measure ROM before myotomy. Based on the ROM values before and after the myotomy, the degree of total, myogenic, and arthrogenic contracture was calculated, according to the method described by Trudel and Uhthoff. 12 The formulae used were as follows:
(1) decrement in ROM as a result of immobilization (total contracture) ¼ ROM before myotomy (of the control knee) À ROM before myotomy (of the contractured knee); (2) decrement in ROM as a result of myogenic contracture ¼ [ROM after myotomy (of the contractured knee) À ROM before myotomy (of the contractured knee)] À [ROM after myotomy (of the control knee) À ROM before myotomy (of the control knee)]; and (3) decrement in ROM as a result of arthrogenic contracture ¼ ROM after myotomy (of the control knee) À ROM after myotomy (of the contractured knee).
Measurement of Muscle Length
After the ROM measurements had been performed, the semitendinosus muscles of both hindlimbs were harvested, with the ischial tuberosity and tibia attached, and fixed using a modified version of the method of Okita et al. 28 In brief, to avoid muscle contraction as a result of immersion in fixative solution, the ischial tuberosity and tibia were clamped using clips and the muscle was stretched with a 16 g sinker via two pulleys and fixed in 0.1M phosphate-buffered 4% paraformaldehyde (pH 7.4) for 4 h at room temperature. After tissue fixation, muscle length was measured using manual calipers, and muscle length ratio was calculated (the length of the immobilized side divided by that of the contralateral control side).
Histological Assessment Tissue Preparation
After the ROM measurements had been conducted, the knee joints were harvested and immersion-fixed in 0.1M phosphate-buffered 4% paraformaldehyde (pH 7.4) for 48 h at 4˚C. During fixation, the knee joints were kept at a flexion angle of approximately 90˚. After fixation, samples were decalcified in 17.7% ethylenediaminetetraacetic acid (pH 7.2, OSTEOSOFT; Merck Millipore, Darmstadt, Germany) for 4 weeks, at room temperature. Knee joints were then cut into two pieces along the sagittal plane and embedded in paraffin. Specimens were cut into 4 mm sagittal sections at the level of medial midcondylar, using microtome.
Histological Observation and Morphometrical Analysis of Joint Capsules
The sections were stained with either hematoxylin and eosin (HE) or aldehyde fuchsin-Masson Goldner (AFMG) for histopathological observation. The posterior region of the knee joint in the AFMG-stained section was photographed at 2Â magnification and the synovial lengths of the posterior joint capsule were measured according to a previous study. 29 In brief, the synovial lengths were measured between the femur-synovium junction and the meniscus (the postero-superior synovial length) and between the meniscus and the tibia-synovium junction (the postero-inferior synovial length) (Fig. 1B) . The sum of the postero-superior and postero-inferior synovial lengths was calculated as the total synovial length.
The thickness of the posterior joint capsule was measured as described in a previous study. 30 In brief, the distance between the posterior borders of the meniscus and the joint capsule was measured as joint capsule thickness (Fig. 1B) . ImageJ software (National Institutes of Health, Bethesda, MD) was used to measure both the synovial lengths and joint capsule thickness.
Calculation of Joint Capsule Collagen Density
Collagen density was calculated using a modification of the method used by Campbell et al. 24 In AFMG-stained sections, the posterior joint capsule just behind the meniscus was captured at 20Âmagnification and analyzed using ImageJ. Using the Split Channels function, the areas of green color, which represented collagen, were isolated from the original color image. Using the Threshold function, an arbitrary threshold was set to determine the area of green-stained collagen tissue. The arbitrary threshold was chosen to the threshold determined channel area become identical to the area of green-stained collagen tissue. The collagen density was calculated by dividing the green-stained area by the total joint capsule area.
Count of Total and Proliferating Cells
To label proliferating cells, rats were injected intraperitoneally with bromodeoxyuridine (BrdU, 50 mg/kg) at 2 and 4 h prior to being sacrificed. BrdU-positive cells were proliferating just prior to sacrifice. To visualize the BrdU-positive cells, immunohistochemistry was performed using an Immunohistochemistry Kit (Abcam, Tokyo, Japan) according to the manufacturer's instructions. Cell nuclei were visualized by counterstaining with hematoxylin. For quantitative analysis, the superior, central, and inferior regions of the posterior joint capsule in each section were photographed at 40Â magnification (Fig. 1C) , and both total and BrdU-positive cells were counted manually. Densities of total and BrdUpositive cells were expressed as number per mm 2 joint capsule.
Gene Expression Analysis of IL-1b and Fibrosis-Related Factors
Twenty-micrometer sagittal sections of the lateral side of the knee were cut using a microtome and the posterior joint capsule was isolated using tweezers, under a stereomicroscope. Total RNA was extracted from paraffin sections using RNeasy FFPE Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Using total RNA and the SuperScript III First-strand synthesis system (Invitrogen, Grand Island, NY), cDNA was prepared by reverse transcription according to the manufacturer's instructions. A total of 21 ml of cDNA samples were obtained using a quantity of 0.29 mg template RNA in average (0.03-0.61 mg). Quality of RNA was checked not by measuring OD260/280, but by observing amplification curves of cDNA products of all the samples during real-time PCR, all of which are quite close to the curve of the positive control whose OD260/280 was 2.03 and its quality was confirmed. Thus, our samples of RNA used in this study had a quality that meets to real-time PCR analysis. cDNA samples were then stored at À20˚C until they were used for real-time PCR.
TaqMan probe-based real-time PCR reactions were performed using the 7300 Real Time PCR System (Applied Biosystems, Foster City, CA). TaqMan primer and probe sets for interleukin-1b (IL-1b; Rn00580432_m1), transforming growth factor-b1 (TGF-b1; Rn00572010_m1), type I collagen (COL1A1; Rn01463848_m1), type III collagen (COL3A1; Rn01437681_m1), and S18 (Rn01428913_gH) were designed and synthesized by Applied Biosystems. S18 was used as an internal control. Amplification reactions contained 10 ml Master mix, 1 ml TaqMan probe, 1 ml cDNA sample, and 8 ml ultrapure water. Amplification was performed using the following thermal cycling profile: 50˚C for 2 min, 95˚C for 10 min, followed by 40 cycles of 95˚C for 15 s and 60˚C for 1 min. The thresholds were automatically determined by the software. Based on threshold cycle values, quantification of gene expression was performed using the calibration curve method. 31, 32 Statistical Analysis Statistical analyses were performed using Dr. SPSS II for Windows (SPSS Japan Inc., Tokyo, Japan). Distributions were tested for normality using the Shapiro-Wilk test, and for homogeneity of variance with the Levene test. Assumptions of normality were met for all data. For experiments testing numbers of BrdU-positive cells and gene expression of IL-1b, which assumptions of homoscedasticity were not met for variables, we used one-way ANOVA and the GamesHowell test. Otherwise, we used a one-way ANOVA and Tukey's post hoc test. For all tests, a p-value <0.05 was considered statistically significant.
RESULTS
Changes in ROM During Remobilization
Before the myotomy, knee extension ROM was 157 AE 6˚for the control (Fig. 2A) . After 3 weeks of immobilization (day 0), ROM before the myotomy was 87 AE 5˚, significantly smaller than that in the control (p < 0.001). ROM increased during remobilization in a time-dependent manner, and reached 120 AE 6˚on day 14, but was still significantly lower than that of the control (p < 0.001).
After the myotomy, knee extension ROM was 159 AE 3˚in the control (Fig. 2B) . On day 0, ROM after the myotomy was 137 AE 5˚, significantly smaller than the control (p < 0.001). Following the myotomy, ROM decreased further after remobilization, and reached its minimum on day 7, at 120 AE 3˚(p < 0.001 compared with day 0).
We calculated contributions of the myogenic and arthrogenic components to the total contracture based on the ROM results from before and after the myotomy (Fig. 2C) . On day 0, myogenic contracture contributed more than arthrogenic contracture. However, the contribution of myogenic contracture gradually decreased during the remobilization period, while that of arthrogenic contracture increased. By day 14, total contracture had almost halved, but the contracture that remained was mainly arthrogenic.
Recovery of Shortened Muscle Length During Remobilization
The muscle length ratio was reduced to 90% on day 0 (Fig. 3) . During remobilization it increased in a time-dependent manner, and by day 14 had reached 97%, significantly greater than that on day 0 (p ¼ 0.005). Ã , significant difference from the control (p < 0.05); †, significant difference from day 0 (p < 0.05).
REMOBILIZATION-INDUCED ARTHROFIBROSIS IN RATS
Histological Changes to the Joint Capsule During Remobilization In the control, the posterior joint capsule was thin and the synovial membrane near the synovial-cartilage junction was deeply folded (Fig. 4A and G) . The postero-superior joint capsule was occupied by fibroadipose tissues (Fig. 4G ) and the postero-central joint capsule was predominantly composed of fibrous tissue whose collagen bundles were thick and loosely arranged (Fig. 4M) . On day 0, the folding of the synovial membrane in the postero-superior joint capsule was shallow ( Fig. 4B and H) , and the collagen bundles in the postero-central joint capsule were thinner than those in the control (Fig. 4N) . On day 1, deposits in the posterior joint space were detected (Fig. 4C , asterisks in Fig. 4I ). In the posterior joint capsule there was also an edema ( Fig. 4C and O) . On day 3, deposits were still apparent in the joint space (Fig. 4D , asterisks in Fig. 4J ), but the joint capsule edema had diminished (Fig. 4P) . By day 7, the postero-superior fibroadipose tissue and deposits in the joint space had In the control, synovial folds were deep (A and arrowheads in G) and collagen bundles were thick and loosely arranged (M). After 3 weeks of immobilization (day 0), the depth of the synovial folds had decreased (B and arrowheads in H) and the collagen bundles had become thinner (N). On day 1 of remobilization, there were deposits in the joint space (C and asterisks in I), edema, and inflammatory cell infiltration (O). On day 3 of remobilization, the deposits were still apparent (D and asterisks in J), but the edema of the joint capsule had diminished (P). On days 7 and 14 of remobilization, the postero-superior fibroadipose tissue and deposits had been replaced by fibrous tissue, which obstructed the synovial folds (arrows in K and L). Finally, the density of collagen content in the joint capsule increased, as indicated by the narrowed gaps between collagen bundles (R). been replaced by fibrous tissue, which caused the folding of the synovial membrane in the posterosuperior joint capsule to disappear (Fig. 4E and K) . On day 14, the joint capsule was densely packed, as indicated by the narrowed gaps between collagen bundles in the postero-central joint capsule (Fig. 4R ).
Synovial Length Shortened by Both Immobilization and Remobilization
Postero-inferior synovial length was significantly reduced on day 0 compared with the control (58% of the control, p < 0.001). During remobilization, there were no significant changes in the length of the posteroinferior synovial capsule (Fig. 5A) .
Immobilization also significantly shortened the postero-superior synovial length compared with the control (75% of the control, p < 0.001). During remobilization, the length of the postero-superior synovial capsule was further reduced, until day 7. On days 7 and 14 of the remobilization, the postero-superior synovial length was significantly shorter than that on day 0 (67 and 70% of day 0, respectively, Fig. 5A , p 2 0.001).
Similarly, total synovial length decreased significantly as a result of immobilization (72% of the control, p < 0.001) and was further reduced by remobilization, until day 7. Total synovial length was significantly shorter on days 7 and 14 of remobilization than that on day 0 of remobilization (75% and 76% of day 0, respectively, Fig. 5A , p ¼ 0.001).
Temporary Increase in Joint Capsule Thickness as a Result of Remobilization
Immobilization did not significantly change joint capsule thickness relative to the control (132% of the control, Fig. 5B ). During remobilization, joint capsule thickness temporarily increased on day 1 (165% of day 0, p < 0.001), mostly as a result of edema, and decreased thereafter in a time-dependent manner, to return to pre-remobilization levels by day 14 (93% of day 0).
Densely Packed Collagen Fibers in the Synovium Following Remobilization
There was no difference between the control and day 0 with respect to the collagen density of the posterocentral joint capsule (60 AE 8% and 59 AE 3%, respectively, Fig. 5C ). On day 1, collagen density temporarily decreased to 47 AE 4% (p ¼ 0.023 compared with day 0), possibly because of the edema, and gradually increased once again thereafter. By day 14, collagen density had reached 79 AE 4% and was significantly higher than in the control and on day 0 (p < 0.001).
Changes in the Total Number of Cells and the Number of BrdU-Positive Cells During Remobilization
In the control (Fig. 6A) , we observed spindle-shaped fibroblasts and vascular endothelial cells in the posterior joint capsule, and no inflammatory cell infiltration. On day 0 (Fig. 6B) , there were no apparent signs Ã , significant difference from the control (p < 0.05); †, significant difference from day 0 (p < 0.05).
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of inflammation in the joint capsule. By day 1 (Fig. 6C) , however, erythrocytes and infiltrated inflammatory cells were present, in addition to the fibroblasts and vascular endothelial cells. By day 3 (Fig. 6D) , the infiltrated cells had largely disappeared, and fibroblasts became predominant. On days 7 (Fig. 6E) and 14 (Fig. 6F) , there were many fibroblasts and no inflammatory cells.
Cell proliferation was quantitatively analyzed by counting the total number of cells and the number of BrdU-positive cells per unit area of joint capsule (cell number/mm 2 ). The total cell count includes cells reacting to inflammation, vascular endothelial cells, and fibroblasts, while the cells that stain positive for BrdU are specifically those that are actively dividing. Relative to the control (Fig. 6G) , immobilization did not significantly affect total cell numbers (77% of the control, Fig. 6H and M) . During remobilization, the total number of cells gradually increased until day 7 ( Fig. 6I-K) , and on days 7 and 14 ( Fig. 6K and L) it was significantly larger than in the control and on day 0 (164% and 153% of the control, respectively, p < 0.01 compared with the control).
Before remobilization, BrdU-positive cells were rare across the entire joint capsule (Fig. 6G, H, and N) .
During remobilization, numbers of BrdU-positive cells rapidly increased, and peaked on day 3 (11-fold those for the control, Fig. 6I and J) . They then gradually decreased and returned to their original (before remobilization) level by day 14 (Fig. 6K and L) . One-way ANOVA revealed that remobilization increased the numbers of BrdU-positive cells (p < 0.001, one-way ANOVA), but multiple comparisons did not detect significant differences between groups (p > 0.087, Games-Howell test).
Gene Expression
Compared with the control, gene expression of the proinflammatory mediator IL-1b tended to increase as a result of immobilization (ninefold that of the control, Fig. 7A ), but the differences were not significant (p ¼ 0.38). On day 1, IL-1b gene expression was significantly upregulated compared with that in the control (23-fold higher, p < 0.001). Thereafter, IL-1b gene expression gradually decreased, and was not detectable on day 14.
Gene expression of pro-fibrotic cytokine TGF-b1 was not activated by immobilization (96% of the control, Fig. 7B ). However, on day 7, TGF-b1 gene expression was significantly upregulated compared with the control and on day 0 (172% of the control, p ¼ 0.007 compared with the control).
Gene expression levels of both COL1A1 and COL3A1 did not change significantly as a result of immobilization (85% and 55% of the control, respectively, Fig. 7C and D) . During remobilization, gene expression of both COL1A1 and COL3A1 were significantly upregulated on days 7 and 14 compared with the control and on day 0 (approximately 2-3 times higher than those of the control, p < 0.008 compared with the control).
DISCUSSION
This study aimed to elucidate how arthrogenic joint contracture develops, by remobilizing knee joints that were once immobilized. We hypothesized that inflammation of joint capsules triggered by joint remobilization causes the progression of arthrogenic joint contracture by generating arthrofibrosis. Indeed, our results showed that remobilization after 3 weeks of immobilization induced inflammation in the posterior joint capsules within 1 day, followed by fibrosis that resulted in arthrogenic contracture. It is well known that inflammation can induce fibrosis in many fibrotic diseases, including arthrofibrosis. 23, 25, 33, 34 In addition, fibrosis of the joint components is considered as a major inducer of arthrogenic contracture. [35] [36] [37] To our knowledge, this is the first report suggesting a mechanism that leads to arthrogenic contracture during remobilization, i.e., remobilization-induced synovitis after a period of immobilization induces to arthrogenic contracture progression via fibrosis.
Before the myotomy, the joint contracture induced by 3 weeks of immobilization decreased, as a result of remobilization, in a time-dependent manner, but significant ROM restriction remained until day 14 of the remobilization. Recovery of the myogenic contracture as a result of remobilization could be explained by the lengthening of the knee flexor muscles, which was examined using the semitendinosus muscle previously shortened by immobilization. In contrast, arthrogenic contracture developed further during remobilization. Along with the progression of arthrogenic contracture, we observed fibrotic changes characterized by fibrous tissue replacing the fibroadipose tissue and intraarticular deposits, as well as from increased collagen density in the posterior joint capsule. These fibrotic changes must be a primary mechanism responsible for the progression of arthrogenic contracture via shortening and stiffening of the joint capsule. Replacement of intra-articular deposits by fibrous tissue further reduced synovial length by diminishing the synovial folds. With respect to immobilization-induced joint contracture, shortening of the synovium is considered a primary cause of the development of arthrogenic contracture. 29, 38 Moreover, the proportion of collagen content contributes to tensile stiffness in connective tissues of the knee, 39 and the attenuation of collagen accumulation after intra-articular injury as a result of the blocking of TGF-b1 signaling alleviates joint contracture. 35, 36 Inflammatory responses such as edema, inflammatory cell infiltration, and the upregulation of proinflammatory cytokine IL-1b gene expression were observed in the joint capsule as early as day 1 of the remobilization period. However, we did not observe hyperplasia of synovial cells. Thus, a mechanism of remobilization-induced arthritis may be different from that of rheumatoid arthritis or osteoarthritis, because hyperplasia of synovial cells usually appears in these inflammatory states. 40, 41 It is well known that inflammation has a crucial role in triggering fibrosis in many fibrotic diseases. 33, 34 In the joints, inflammatory conditions such as arthritis and intra-articular trauma, Ã , significant difference from the control (p < 0.05); †, significant difference from day 0 (p < 0.05).
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cause joint contracture via fibrosis of joint components, [23] [24] [25] which is called arthrofibrosis. IL-1 and TGF-b1 play a key role in generating arthrofibrosis. 35, 36, 42, 43 Intra-articular injection of IL-1 receptor antagonist anakinra could improve ROM in patients with arthrofibrosis. 42 Fibroblasts produce extracellular matrix structural proteins, including collagens, and thus fibroblast proliferation is an important process in the development of arthrofibrosis. 25, 44 Indeed, IL-1b has been shown to have proliferative effects on synovial fibroblasts sampled from arthritic joints. 45 In this study, cell proliferation during the remobilization period was monitored using cells that stain positive for BrdU. This indicated a trend of increased cell proliferation following IL-1b gene upregulation. The result of this proliferation was hypercellularity, mainly because of increased numbers of fibroblasts, concurrent with the development of arthrofibrosis. These results suggest that IL-1b may contribute to the development of arthrofibrosis via fibroblast proliferation.
TGF-b1 is the most important cytokine affecting the development of fibrotic processes, because it modulates fibroblast function to promote matrix preservation. 46 In fact, suppressing TGF-b1 activity with its antibody or the TGF-b-binding proteoglycan, decorin, prevents arthrofibrosis after intra-articular injury. 35, 36 Similarly, blocking TGF-b downstream signaling by adenoviral-mediated over-expression of Smad6 or Smad7 significantly decreases synovial fibrosis in experimental arthritis models. 47, 48 In this study, the parallel increase in TGF-b1 and type I and III collagen genes that was detected on day 7 of remobilization indicates the upregulation of TGF-b1-mediated joint capsule fibrosis following remobilization. In this study, only few genes were examined. Other factors such as vascular endothelial growth factor 25 and prostaglandin F 2a 49 have also been reported to contribute to the formation of arthrofibrosis in other situations. Therefore, these factors might also contribute to remobilization-induced arthrofibrosis. These possibilities should be tested in future studies.
We speculate that a series of inflammatory and fibrotic reactions were initiated by micro-damage in the joint capsule as a result of remobilization. The appearance of erythrocytes in the posterior joint capsule on day 1 of remobilization ( Fig. 6C) indicates the presence of joint capsule injury, manifested by internal bleeding. Micro-damage in the joint capsule may arise during remobilization, as a result of the relatively higher tensile stress on the weakened and shortened joint capsule that had been immobilized for 3 weeks, because immobilization decreased the collagen bundle thickness as well as length of the joint capsule (synovium). Considering all of the above, we suggest that the remobilization following immobilization for a substantial period caused joint capsule injury, which resulted in subsequent inflammation and arthrofibrosis.
In clinical treatment, passive joint movements such as stretching are started immediately after remobilization to correct joint contracture. However, a clinical study revealed that passive stretching is not effective for immobilization-induced joint contracture. 7 Moreover, our study has indicated that remobilization causes inflammation and fibrosis in the joint capsule. Application of intensive joint movement after remobilization may thus have unfavorable effects on the recovery processes of joint contracture, and should be reconsidered. On the other hand, our results suggest that anti-inflammatory/fibrosis therapies during remobilization may counteract immobilization-induced joint contracture.
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